These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6688789)

  • 1. Response to the society of toxicology task force re-examination of the ED01 study.
    Kodell RL; Gaylor DW; Greenman DL; Littlefield NA; Farmer JH
    Fundam Appl Toxicol; 1983; 3(4):3a-12a. PubMed ID: 6688789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling time-to-tumor data: analysis of the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):458-69. PubMed ID: 6642103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data systems support for a large, long-term carcinogenic (ED01) study.
    Taylor DW; Johnson CL
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):221-30. PubMed ID: 7365383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ED01 study: introduction, objectives, and experimental design.
    Cairns T
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):1-7. PubMed ID: 7365374
    [No Abstract]   [Full Text] [Related]  

  • 6. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study.
    Cohen SM; Ellwein LB
    Toxicol Appl Pharmacol; 1990 Jun; 104(1):79-93. PubMed ID: 2360210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-examination of the ED01 study - adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):67-80. PubMed ID: 7184775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of agreement among findings of pathologists in ED01 experiment.
    Amato DA; Lagakos SW
    J Natl Cancer Inst; 1988 Aug; 80(12):919-25. PubMed ID: 3398066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ED01 study: summary and conclusions.
    Gaylor DW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):179-83. PubMed ID: 7365380
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-examination of the ED01 study. Review of statistics: the need for realistic statistical models for risk assessment.
    Fundam Appl Toxicol; 1981; 1(1):124-6. PubMed ID: 7184771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multistage prediction of cancer in serially dosed animals with application to the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):470-7. PubMed ID: 6642104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological model of ED01 hepatocarcinogenesis.
    Travis CC; Zeng C; Nicholas J
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):19-29. PubMed ID: 8806866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fitting the two-stage clonal expansion model based on exact hazard to the ED01 data using SAS NLIN.
    Lensing SY; Kodell RL
    Risk Anal; 1995 Apr; 15(2):233-45. PubMed ID: 7597259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point estimates of cancer risk at low doses.
    Gaylor DW; Kodell RL; Chen JJ; Springer JA; Lorentzen RJ; Scheuplein RJ
    Risk Anal; 1994 Oct; 14(5):843-50. PubMed ID: 7800868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty analysis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) cancer dose-response for three occupational cohorts.
    Dong Z; Yuan G; Hu J
    Environ Int; 2016 Mar; 88():53-59. PubMed ID: 26708281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Vogelstein: How the 2012 AAP Task Force on circumcision went wrong.
    Van Howe RS
    Bioethics; 2018 Jan; 32(1):77-80. PubMed ID: 28691236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The linearized multistage model and the future of quantitative risk assessment.
    Crump KS
    Hum Exp Toxicol; 1996 Oct; 15(10):787-98. PubMed ID: 8906427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of low-dose carcinogenicity.
    Armitage P
    Biometrics; 1982 Mar; 38 Suppl():119-39. PubMed ID: 7046818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated and computer-assisted pathology support for a large chronic study.
    Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):231-46. PubMed ID: 7365384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.